Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma by Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N

Subjects: “…pasireotide…”
Get full text

The position of combined medical treatment in acromegaly by Eva C. Coopmans, Sebastiaan W. F. van Meyel, Aart J van der Lely, Sebastian J. C. M. M. Neggers

Subjects: Get full text

Pasireotide: A new option for treatment of acromegaly by Filiz Eksi Haydardedeoglu, Okan Bakiner

Subjects: Get full text

The Effect of 6 Months’ Treatment With Pasireotide LAR on Glucose Metabolism in Patients With Resistant Acromegaly in Real-World Clinical Settings by Przemysław Witek, Marek Bolanowski, Katarzyna Szamotulska, Agnieszka Wojciechowska-Luźniak, Aleksandra Jawiarczyk-Przybyłowska, Marcin Kałużny

Subjects: Get full text

Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report by A. Ciresi, S. Radellini, V. Guarnotta, C. Giordano

Subjects: “…Pasireotide…”
Get full text

Risk factors and management of pasireotide-associated hyperglycemia in acromegaly by Mônica R Gadelha, Feng Gu, Marcello D Bronstein, Thierry C Brue, Maria Fleseriu, Ilan Shimon, Aart J van der Lely, Shoba Ravichandran, Albert Kandra, Alberto M Pedroncelli, Annamaria A L Colao

Subjects: “…pasireotide…”
Get full text

Successful debulking of plurihormonal pituitary macroadenoma with long‐acting pasireotide and dopamine agonist combination therapy by Terri W. Jerkins, Randy K. Jerkins, Robbi Franklin

Subjects: Get full text

Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion by Rouland A, Bouillet B, Legris P, Simoneau I, Petit JM, Vergès B

Subjects: Get full text

Manejo de hiperglucemia asociada al uso de pasireotida en pacientes con enfermedad de Cushing o acromegalia. Recomendaciones de un panel de expertos by Alejandro Pinzón-Tovar, Alin Abreu Lomba, Henry Mauricio Arenas, Claudia Milena Gomez Giraldo, Doly Pantoja Guerrero, Alex Valenzuela, Andrés Felipe García, Nathalia Buitrago Gómez

Subjects: Get full text

Pasireotide use for the treatment of endogenous hyperinsulinemic hypoglycemia refractory to conventional medical therapy: A case report and review of the literature by Hasan Husni, Sara A. Khan, Buraq Alghaieb, Mohammed S. Abusamaan, Thomas W. Donner, Amir H. Hamrahian

Subjects: Get full text

Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement by Sang Ouk Chin, Cheol Ryong Ku, Byung Joon Kim, Sung-Woon Kim, Kyeong Hye Park, Kee Ho Song, Seungjoon Oh, Hyun Koo Yoon, Eun Jig Lee, Jung Min Lee, Jung Soo Lim, Jung Hee Kim, Kwang Joon Kim, Heung Yong Jin, Dae Jung Kim, Kyung Ae Lee, Seong-Su Moon, Dong Jun Lim, Dong Yeob Shin, Se Hwa Kim, Min Jeong Kwon, Ha Young Kim, Jin Hwa Kim, Dong Sun Kim, Chong Hwa Kim

Subjects: Get full text

Individualized medical treatment options in Cushing disease by Aleksandra Gilis-Januszewska, Anna Bogusławska, Ewelina Rzepka, Witold Ziaja, Alicja Hubalewska-Dydejczyk

Subjects: Get full text

Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing’s disease by Richard A. Feelders, Maria Fleseriu, Pinar Kadioglu, Marie Bex, Deyanira González-Devia, Cesar Luiz Boguszewski, Dilek Gogas Yavuz, Heather Patino, Alberto M. Pedroncelli, Alberto M. Pedroncelli, Ricardo Maamari, Arghya Chattopadhyay, Beverly M. K. Biller, Rosario Pivonello

Subjects: Get full text

Pasireotide after Surgery for Persistent Cushing’s Disease by Dan Nicolae PADURARU, Carla SCANTEIE, Alexandra BOLOCAN, Octavian ANDRONIC, Andra MORAR, Cristina GHERVAN, Raluca CIUNT, Bogdan SOCEA, Ovidiu BRATU, Laura Maria DRAGOMIR, Mara CARSOTE, Ana VALEA

Subjects: Get full text

Pasireotide treatment for severe congenital hyperinsulinism due to a homozygous ABCC8 mutation by Christiaan F. Mooij, Carline E. Tacke, Mirjam E. van Albada, Winfried Barthlen, Hennie Bikker, Klaus Mohnike, Matthijs W.N. Oomen, A.S. Paul van Trotsenburg, Nitash Zwaveling-Soonawala

Subjects: Get full text

Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide by Kevin Doello, Maria Angeles Chico, Francisco Quiñonero, Raúl Ortiz, Jose Prados, Cristina Mesas, Consolación Melguizo

Subjects: Get full text

Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain by Sánchez-Cenizo L, Aller J, Martínez-Sesmero JM, Mir N, Peral C, Rubio-Rodríguez D, Rubio-Terrés C

Subjects: Get full text

Pasireotide-LAR in acromegaly patients treated with a combination therapy: a real-life study by Hélène Lasolle, Amandine Ferriere, Alexandre Vasiljevic, Sandrine Eimer, Marie-Laure Nunes, Antoine Tabarin

Subjects: Get full text

Loss of efficacy of pasireotide after its re-administration: is there a reason why? by Stylianos Mandanas, Lemonia Mathiopoulou, Maria Boudina, Alexandra Chrisoulidou, Kalliopi Pazaitou-Panayiotou

Subjects: Get full text

Pituitary gigantism due to a novel AIP germline splice-site variant by Elisa Lamback, Renan Lyra Miranda, Leila Chimelli, Felipe Andreiuolo, Leandro Kasuki, Luiz Eduardo Wildemberg, Mônica R Gadelha

Subjects: Get full text